Sign in Subscribe

TIM

FDA Oversight Is Losing Resolution — And Industry May Increasingly Be Expected to Close the Gap

GAO warnings that FDA oversight is constrained by data gaps and complexity suggest a quiet shift in expectations, with industry increasingly expected to supply clearer, earlier, and more continuous evidence of risk control.

The FBI’s AI inventory isn’t transparency — it’s pre-enforcement infrastructure

The FBI’s disclosure that it inventories AI systems signals more than transparency. By formally mapping where and how AI is used, the agency is laying groundwork for future oversight, auditability, and constraint without new law.

The AI credit reset has begun — and it’s breaking SaaS-era financing assumptions

Credit markets are reassessing AI-heavy software revenue as less durable than SaaS-era models assumed, tightening terms and repricing risk even where growth metrics remain strong.

February 2026 Intelligence Brief: From Principles to Execution

February 2026 marks a shift from policy principles toward execution, as AI governance guidance and fiscal signals converge, narrowing planning flexibility without fully resolving outcomes for regulators or markets.

Gold at $5,000 May Be Less a Market Story — and More a Governance Signal

Gold’s rapid move past $5,000 appears less tied to inflation and more to investor uncertainty around policy predictability and institutional response, signaling a broader reassessment of confidence rather than a single market shock.

TikTok’s U.S. Restructuring Reframed How Data Is Governed

TikTok’s updated U.S. privacy policy clarifies that AI prompts, precise location data, and off-platform activity are treated as persistent first-party data, reshaping how post-restructuring governance and oversight are evaluated.

AI Disclosures Are Moving Toward Audit-Style Scrutiny

Regulatory scrutiny of AI disclosures is increasingly focused on whether public claims can be supported with documented controls and evidence, signaling a shift from narrative explanations toward audit-style inspection readiness.

Daily Operator Edition — Jan 26, 2026

Decision-grade regulatory intelligence covering FINRA arbitration rule cutovers, HHS OCR guidance rescissions, sanctions posture continuity, and emerging FCC compliance signals.

Healthcare AI Is Entering a Regulatory Gray Zone Without Formal Reclassification

Healthcare AI platforms are increasingly synthesizing and interpreting patient data over time while remaining outside formal clinical regulation, creating a gray zone where evidentiary and governance expectations are still undefined.

Daily Operator Edition — Jan 23, 2026

Decision-grade regulatory intelligence covering FINRA renewal enforcement, OFAC sanctions updates, and emerging SEC market-structure and CAT reporting compliance risks.